BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30201903)

  • 1. Melatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction.
    Wang TH; Hsueh C; Chen CC; Li WS; Yeh CT; Lian JH; Chang JL; Chen CY
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 3. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
    Zhao L; Wang Y; Liu Q
    Exp Mol Pathol; 2019 Aug; 109():51-60. PubMed ID: 31145886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.
    Qi Y; Yao X; Du X
    IUBMB Life; 2020 Mar; 72(3):452-464. PubMed ID: 31651086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
    Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
    J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X; Fan W; Chen Y
    Gene; 2018 May; 657():30-38. PubMed ID: 29505836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00052/miR-101-3p axis inhibits cell proliferation and metastasis by targeting SOX9 in hepatocellular carcinoma.
    Yan S; Shan X; Chen K; Liu Y; Yu G; Chen Q; Zeng T; Zhu L; Dang H; Chen F; Ling J; Huang A; Tang H
    Gene; 2018 Dec; 679():138-149. PubMed ID: 30098428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
    Tan W; Lim SG; Tan TM
    World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.
    Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y
    J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
    Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH
    Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.
    Tang B; Lei B; Qi G; Liang X; Tang F; Yuan S; Wang Z; Yu S; He S
    J Exp Clin Cancer Res; 2016 Jun; 35(1):93. PubMed ID: 27306418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
    Ghousein A; Mosca N; Cartier F; Charpentier J; Dupuy JW; Raymond AA; Bioulac-Sage P; Grosset CF
    Liver Int; 2020 Jan; 40(1):240-251. PubMed ID: 31612616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-520c-3p Modulates Doxorubicin-Chemosensitivity in HepG2 Cells.
    Ragheb MA; Soliman MH; Elzayat EM; Mohamed MS; El-Ekiaby N; Abdelaziz AI; Abdel-Wahab AA
    Anticancer Agents Med Chem; 2021; 21(2):237-245. PubMed ID: 32357822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
    Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
    Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma.
    Soliman MH; Ragheb MA; Elzayat EM; Mohamed MS; El-Ekiaby N; Abdelaziz AI; Abdel-Wahab AA
    Anticancer Agents Med Chem; 2021; 21(2):246-253. PubMed ID: 32416702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.